STOCK TITAN
  1. Home
  2. Sec-filings
  3. CING
  4. [Form 4] Cingulate Inc. Insider Trading Activity

Cingulate Inc. (CING) grants director stock options on 20,000 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Cingulate Inc. director Peter J. Werth received a grant of stock options for 20,000 shares of common stock on July 16, 2026. The options have an exercise price of $4.43 per share and expire on July 16, 2036. They vest on the earlier of the one-year anniversary of the grant date or the date of Cingulate Inc.'s 2027 annual meeting of stockholders, leaving Werth with 20,000 stock options held directly.

Positive

  • None.

Negative

  • None.
Insider Werth Peter J.
Role Director
Type Security Shares Price Value
Grant/Award Stock Option (right to Buy) F1 20,000 $0.00 $0.00
Holdings After Transaction: Stock Option (right to Buy) — 20,000 shares (Direct)
Footnotes (1)
  1. F1. The option vests on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Cingulate Inc. 2027 annual meeting of stockholders.
Stock options granted 20,000 options Grant to director Peter J. Werth on July 16, 2026
Exercise price $4.43 per share Exercise price for the 20,000 stock options
Option expiration date July 16, 2036 Expiration for the granted stock options
Options held after grant 20,000 options Total stock options held directly by Peter J. Werth after the award
Stock Option (right to Buy) financial
"The security is described as a Stock Option (right to Buy)."
exercise price financial
"The options have an exercise price of $4.43 per share."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
annual meeting of stockholders financial
"The option vests by the date of the 2027 annual meeting of stockholders."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What stock option grant did Peter J. Werth report for Cingulate (CING)?
Peter J. Werth received 20,000 stock options for Cingulate (CING) common stock. These options were granted on July 16, 2026, providing the right to buy Cingulate shares under specified terms, including a fixed exercise price and a long-dated expiration.

What is the exercise price of the new Cingulate (CING) options granted to Peter J. Werth?
The granted options have an exercise price of $4.43 per share. This means Werth can purchase Cingulate (CING) common stock at $4.43 per share upon exercise, regardless of the market price at the time he chooses to exercise, subject to vesting.

When do Peter J. Werth’s Cingulate (CING) stock options vest?
The options vest on the earlier of one year from the grant date or the date of Cingulate Inc.'s 2027 annual meeting of stockholders. This structure ties vesting to both time in role and the company’s annual governance cycle.

When do the newly granted Cingulate (CING) stock options to Peter J. Werth expire?
The options expire on July 16, 2036. After this date, Peter J. Werth will no longer be able to exercise these Cingulate (CING) stock options, even if they are vested and otherwise exercisable before the expiration date.

How many Cingulate (CING) stock options does Peter J. Werth hold after this grant?
Following this grant, Peter J. Werth holds 20,000 stock options in Cingulate (CING) directly. All of these options relate to Cingulate common stock and reflect his derivative equity position as reported after the award.

What type of security was granted to Peter J. Werth in Cingulate (CING)?
He received a Stock Option (right to Buy) tied to Cingulate (CING) common stock. Each option represents the right to purchase one share of common stock at the specified exercise price once vesting conditions are satisfied.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Werth Peter J.
(Last)(First)(Middle)
1901 W. 47TH PLACE
(Street)
KANSAS CITY KANSAS 66205
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Cingulate Inc. [ CING ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/16/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to Buy)$4.4307/16/2026A20,000 (1)07/16/2036Common Stock20,000$020,000D
Explanation of Responses:
1. The option vests on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Cingulate Inc. 2027 annual meeting of stockholders.
/s/ Shane J. Schaffer, Attorney-in-Fact07/20/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR